Del Rio M - Search Results

1

Correction of recessive dystrophic epidermolysis bullosa by homology-directed repair-mediated genome editing.

Bonafont J, Mencía A, Chacón-Solano E, Srifa W, Vaidyanathan S, Romano R, Garcia M, Hervás-Salcedo R, Ugalde L, Duarte B, Porteus MH, Del Rio M, Larcher F, Murillas R. Bonafont J, et al. Among authors: del rio m. Mol Ther. 2021 Jun 2;29(6):2008-2018. doi: 10.1016/j.ymthe.2021.02.019. Epub 2021 Feb 18. Mol Ther. 2021. PMID: 33609734 Free PMC article.

2

Antiproliferative effects of PCA-4230, a new antithrombotic drug, in vascular smooth muscle cells.

del Rio M, Sunkel C, Larcher F, Ortega MP. del Rio M, et al. Br J Pharmacol. 1997 Apr;120(7):1360-6. doi: 10.1038/sj.bjp.0701035. Br J Pharmacol. 1997. PMID: 9105713 Free PMC article.

3

A cutaneous gene therapy approach to human leptin deficiencies: correction of the murine ob/ob phenotype using leptin-targeted keratinocyte grafts.

Larcher F, Del Rio M, Serrano F, Segovia JC, Ramírez A, Meana A, Page A, Abad JL, González MA, Bueren J, Bernad A, Jorcano JL. Larcher F, et al. Among authors: del rio m. FASEB J. 2001 Jul;15(9):1529-38. doi: 10.1096/fj.01-0082com. FASEB J. 2001. PMID: 11427484

4

Growth inhibitory activity of indapamide on vascular smooth muscle cells.

Ganado P, Ruiz E, Del Rio M, Larcher F, Sanz M, Steinert JR, Tejerina T. Ganado P, et al. Among authors: del rio m. Eur J Pharmacol. 2001 Sep 28;428(1):19-27. doi: 10.1016/s0014-2999(01)01275-4. Eur J Pharmacol. 2001. PMID: 11779033

5

A preclinical model for the analysis of genetically modified human skin in vivo.

Del Rio M, Larcher F, Serrano F, Meana A, Muñoz M, Garcia M, Muñoz E, Martin C, Bernad A, Jorcano JL. Del Rio M, et al. Hum Gene Ther. 2002 May 20;13(8):959-68. doi: 10.1089/10430340252939069. Hum Gene Ther. 2002. PMID: 12031128

6

A comparison of targeting performance of oncoretroviral versus lentiviral vectors on human keratinocytes.

Serrano F, Del Rio M, Larcher F, Garcia M, Muñoz E, Escamez MJ, Muñoz M, Meana A, Bernad A, Jorcano JL. Serrano F, et al. Among authors: del rio m. Hum Gene Ther. 2003 Nov 1;14(16):1579-85. doi: 10.1089/104303403322495089. Hum Gene Ther. 2003. PMID: 14577919

7

Human plasma as a dermal scaffold for the generation of a completely autologous bioengineered skin.

Llames SG, Del Rio M, Larcher F, García E, García M, Escamez MJ, Jorcano JL, Holguín P, Meana A. Llames SG, et al. Among authors: del rio m. Transplantation. 2004 Feb 15;77(3):350-5. doi: 10.1097/01.TP.0000112381.80964.85. Transplantation. 2004. PMID: 14966407

8

Inhibition of xenografted human melanoma growth and prevention of metastasis development by dual antiangiogenic/antitumor activities of pigment epithelium-derived factor.

Garcia M, Fernandez-Garcia NI, Rivas V, Carretero M, Escamez MJ, Gonzalez-Martin A, Medrano EE, Volpert O, Jorcano JL, Jimenez B, Larcher F, Del Rio M. Garcia M, et al. Among authors: del rio m. Cancer Res. 2004 Aug 15;64(16):5632-42. doi: 10.1158/0008-5472.CAN-04-0230. Cancer Res. 2004. PMID: 15313901

9

Current approaches and perspectives in human keratinocyte-based gene therapies.

Del Rio M, Gache Y, Jorcano JL, Meneguzzi G, Larcher F. Del Rio M, et al. Gene Ther. 2004 Oct;11 Suppl 1:S57-63. doi: 10.1038/sj.gt.3302370. Gene Ther. 2004. PMID: 15454958 Review.

10

A cutaneous gene therapy approach to treat infection through keratinocyte-targeted overexpression of antimicrobial peptides.

Carretero M, Del Río M, García M, Escámez MJ, Mirones I, Rivas L, Balague C, Jorcano JL, Larcher F. Carretero M, et al. Among authors: del rio m. FASEB J. 2004 Dec;18(15):1931-3. doi: 10.1096/fj.04-1515fje. Epub 2004 Sep 29. FASEB J. 2004. PMID: 15456737

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

592 results

Search Page